The French city of Bordeaux will speed up vaccinations for residents of a neighborhood after nearly 50 people tested positive for a “very rare” variant of COVID-19, health authorities said Friday.
All adult North Bacalan residents of the city neighborhood he will be granted “unconditional” access to the spikes, “this weekend or, at worst, early next week,” said Patrick Dehail, a medical adviser to the regional health authority.
“We are working with the (Health) ministry to obtain the necessary additional doses, ”Dehail said, adding that the local effort driven will be extended to the wider area of Bordeaux.
“We are talking about a variant that has already been identified nationally but has so far been very rare,” he added.
At least 46 people have been infected with the variant in the Bordeaux district, with massive tests launched on Friday to locate other cases. None of those infected so far have been hospitalized.
Labeled as VOC 20I / 484K, the strain is related to the British variant of COVID-19, but with an additional mutation.
This mutation (E484K) is also carried by the South African and Brazilian variants and is suspected to reduce the immunity acquired by a past infection or by some vaccines.
However, Dehail said there was still “no reason” to suggest that the variant be resistant to mRNA vaccines such as those made by Pfizer or Moderna, or that it causes a more severe form of COVID-19.
The variant has been detected in the north of the Paris region, as well as in Bordeaux, in the southwest of France.
In France as a whole, vaccines have so far been limited to those over 50, although people who are not part of this age group can reserve unused advertising space advertised at short notice. All adults can be vaccinated in France from 31 May.
© 2021 AFP
Citation: Race to vaccinate in Bordeaux as a rare variant detected (2021, May 21) recovered on May 21, 2021 at https://medicalxpress.com/news/2021-05-vaccinate-bordeaux-rare-variant.html
This document is subject to copyright. Apart from any fair treatment for the purposes of private study or research, no part may be reproduced without written permission. Content is provided for informational purposes only.